Product Name	Fluorescence immunoassay analyzer
Catalog No.	PS-00198
Description	Fluorescence immunoassay analyzer is a highly sensitive instrument for the detection of target substances in biological samples. It works by means of antibodies labeled with fluorescent molecules that bind to the target substance in the sample and emit a fluorescent signal under the irradiation of an excitation light source. By detecting and quantifying this fluorescent signal, the instrument can quickly and accurately analyze the concentration of the target substance in the sample.
Detection Principle	Fluorescence immunoassy
Sample Type	Urine, plasma, serum, whole blood, swab
Testing Time	10 s
Weight	<1.5 kg
Application	It can be used to detect target substances in biological samples and analyze the concentration of target substances in samples quickly and accurately.
Operating Temperature	Operate at 4-30°C.
Transportation Condition	Transportation at room temperature.
Operating Conditions	4-30°C

In recent years, the global demand for rapid, accurate, and accessible in vitro diagnostic (IVD) tools has grown exponentially, driven by the increasing prevalence of infectious diseases, chronic conditions, and the need for point-of-care testing (POCT) in both clinical and non-clinical settings. Traditional diagnostic methods, such as enzyme-linked immunosorbent assay (ELISA) or molecular testing, often require complex laboratory setups, long turnaround times (ranging from hours to days), and specialized technical expertise—limitations that hinder timely diagnosis and treatment decisions, especially in resource-constrained areas, emergency departments, or remote clinics.

Fluorescence immunoassay (FIA) technology has emerged as a game-changer in addressing these challenges. By combining the specificity of antigen-antibody binding with the high sensitivity of fluorescent signal detection, FIA-based instruments offer a balance of speed, accuracy, and ease of use that aligns with the evolving needs of modern healthcare. Unlike conventional methods, FIA analyzers leverage fluorescently labeled antibodies to bind target substances (e.g., proteins, antigens, or biomarkers) in biological samples; when exposed to an excitation light source, these labeled complexes emit a fluorescent signal, which is then quantified to determine the concentration of the target—enabling both qualitative and quantitative analysis.

The Fluorescence Immunoassay Analyzer (Cat.No: PS-00198) is designed to capitalize on the strengths of FIA technology, catering to a wide range of diagnostic scenarios. Its development is rooted in the need to:
Overcome the time constraints of traditional testing: With a testing time of just 10 seconds, it eliminates the delays associated with incubation-heavy methods, critical for emergency cases (e.g., detecting cardiac markers in suspected heart attacks) or infectious disease outbreaks (e.g., rapid screening for pathogens).
Enhance accessibility across settings: Weighing less than 1.5 kg and operating within a 4-30°C temperature range, it is portable enough for bedside testing in hospitals, fieldwork in remote areas, or quick screening in clinics—without requiring strict environmental controls.
Simplify workflow for non-specialists: By automating key steps (e.g., signal detection and quantification) and supporting multiple sample types (urine, plasma, serum, whole blood, swabs), it reduces reliance on trained laboratory staff, making it suitable for primary care facilities or on-site testing (e.g., at airports or workplaces during public health events).

Today, FIA analyzers like PS-00198 play a pivotal role in diverse diagnostic applications, from monitoring chronic diseases (e.g., diabetes, thyroid disorders) to detecting infectious agents (e.g., viruses, bacteria) and screening for cancer biomarkers. As healthcare systems worldwide prioritize early detection and decentralized testing, this analyzer addresses a critical gap in delivering fast, reliable results that drive informed clinical decisions and improve patient outcomes.

Ultra-Fast Testing Speed: Delivers test results in just 10 seconds, significantly outperforming many conventional diagnostic tools (which often take minutes to hours) and enabling immediate clinical action—ideal for emergency departments, urgent care centers, or situations requiring rapid mass screening.
Broad Sample Compatibility: Supports multiple common biological sample types, including urine, plasma, serum, whole blood, and swabs. This eliminates the need for specialized sample processing or conversion, streamlining workflow and reducing the risk of sample contamination or loss.
Compact and Portable Design: Weighs less than 1.5 kg, making it easy to transport and deploy in various settings—from bedside testing in hospitals to fieldwork in remote regions or temporary testing sites (e.g., during disease outbreaks). Its small footprint also saves valuable bench space in laboratories or clinics.
Wide Operating Temperature Range: Functions reliably within 4-30°C, eliminating the need for strict temperature-controlled environments. This enhances its usability in regions with unstable climate conditions or limited access to climate-controlled facilities (e.g., rural clinics or mobile testing units).
Room-Temperature Transportation: Can be transported at room temperature, simplifying logistics and reducing costs associated with cold-chain shipping. This is particularly beneficial for distributing the analyzer to remote or low-resource areas where maintaining cold chains is challenging.
High Sensitivity: Leverages fluorescence immunoassay technology to detect target substances with exceptional sensitivity, ensuring accurate identification of low-concentration biomarkers or analytes—critical for early disease detection (e.g., early-stage cancer markers) or detecting trace pathogens.

Improves Clinical Efficiency: By providing results in 10 seconds, it reduces patient wait times, accelerates treatment decisions, and increases the throughput of testing—helping healthcare facilities handle higher patient volumes without compromising on accuracy. For example, in a busy emergency room, this speed can mean faster diagnosis of conditions like acute myocardial infarction (via cardiac markers) or sepsis (via inflammatory biomarkers), directly improving patient survival rates.
Reduces Operational Complexity: Its compatibility with multiple sample types and lack of strict environmental requirements minimize the need for additional equipment (e.g., sample centrifuges, temperature controllers) or specialized training. This lowers the barrier to entry for smaller clinics, primary care facilities, or non-laboratory settings, expanding access to high-quality diagnostic testing.
Enhances Portability and Accessibility: Weighing under 1.5 kg, it is highly portable compared to larger laboratory-based analyzers (which may weigh 50 kg or more). This allows for decentralized testing—bringing diagnostics closer to patients in remote areas, disaster zones, or underserved communities where access to centralized laboratories is limited.
Ensures Reliable Performance in Diverse Environments: The 4-30°C operating range and room-temperature transportation capability ensure consistent performance regardless of location or climate. Unlike analyzers that require strict temperature control, it avoids performance issues caused by temperature fluctuations, making it a dependable tool for global deployment.
Supports Versatile Diagnostic Applications: Its ability to detect target substances across multiple sample types and high sensitivity make it suitable for a wide range of use cases, including infectious disease screening, chronic disease monitoring, and biomarker detection. This versatility allows healthcare facilities to use a single instrument for multiple diagnostic needs, reducing equipment costs and simplifying inventory management.
Minimizes Contamination Risks: By reducing the need for extensive sample processing (thanks to broad sample compatibility), it limits the number of steps where sample contamination can occur. This improves the reliability of test results and reduces the likelihood of false positives or negatives, which is critical for accurate diagnosis and patient care.

In the field of fluorescence immunoassay and in vitro diagnostics, there are several complementary and similar products that cater to diverse testing needs, aligning with the core functionality of the Fluorescence Immunoassay Analyzer (Cat.No: PS-00198). These include portable dry fluorescence immunoassay POCT analyzers designed for even more compact, on-the-go testing (e.g., for home use or mobile clinics), time-resolved fluorescence immunoassay analyzers that enhance sensitivity by reducing background signals—ideal for detecting ultra-low concentration analytes like rare biomarkers, and multi-channel fluorescence immunoassay analyzers that support simultaneous testing of multiple items (e.g., 2-3 analytes at once) to increase throughput in high-volume laboratories. Additionally, related products include fluorescence immunoassay reagent cards or kits tailored to specific diagnostic applications, such as cardiac marker testing (e.g., troponin, CK-MB), infectious disease detection (e.g., viral or bacterial antigens), thyroid function monitoring (e.g., TSH, T3/T4), and chronic disease management (e.g., HbA1c for diabetes). These related products share the core goal of delivering fast, accurate, and accessible diagnostic results, complementing the capabilities of the PS-00198 analyzer to meet the varied needs of healthcare providers across clinical, laboratory, and field settings. If you are interested in related products, you can directly contact us or inquire about product customization services.

Cat.No	Product Name	Price
PR-0091	Automatic chemiluminescence assay meter	Add To Cart
PS-0089	Automatic biochemistry analyzer	Add To Cart

Fluorescence immunoassay analyzer